The effect of vitagnus on sexual function of Women 50 to 70 years old Referring to the Retirement center of North Khorasan province

Determining the effect of Vitagnus drops on sexual function of women aged 50-70 years old referring to the retired center of North Khorasan province

Clinical practice is a control group with no parallel groups, two blinds. Using the lottery, the intervention group and the placebo are identified. The sample size is 64. phase II clinical trial.

North Khorasan Retirees Association

1- 50-70 year-old women 2-No known psychological illness 3-Lack of emotional stress in the past six months (such as the death of close relatives) 4- In spite of being a spouse and living together with a spouse 5- Absent susceptibility to spices and essential oils 6- Lack of alcohol 7- Not using relaxation methods, hormonal, herbal and nerve drugs 8- Non-participation in similar researcا 9- Absence of a variety of cancers at the time of research 10- Failure to have breast and genital cancer in the past (endometrium, cervix, ovary) 11- Not getting bleeding or spotting 12- Absence of sexually transmitted malformations • 1. Do not use drop for one week • 2. People whose sexual performance is above 23 • 3- Observe spotting or bleeding during research • 4. Use of estrogenic hormone or other herbal drugs of phytoestrogens affect the hormonal status during the research period. • 5. Occurrence of adverse event during research • 6. Sensitization

The research unit is recommended to use 40 drops of vitagnus or placebo with a cold drink for 2 months at the beginning of the morning. The research unit is trained every two weeks, and at the time of being in the center, the amount of drops to be given until the next visit is required. Also, at the intervals of four, six and eight weeks from the onset of intervention, the sexual function questionnaire for the research unit is completed.

Sexual function

Those who have the conditions for entry into the study are given the necessary explanations for the study. A written consent form is signed by the patient and his wife and this way, people enter the study. At first, a demographic and clinical data form is made by the researcher and sexual function of women is completed in the interview. Then, people are classified according to age in four groups: 55-50, 60-55, 65-60 and 65-70 years old. Individuals are assigned code, and the groups are separated and separated by each other, using the lottery of the intervention group and the placebo. People in both groups are homogeneous in terms of age.

After the negotiation and conclusion of the contract with the pharmaceutical company Poursina Drosa Vitagnus, along with placebo, the company will supply the research unit. Both the vials and the placebo drops contain the same visual appearance, and will be inscribed only on the glass of the letters A and B.